Max Robotics — Global Service Robot Directory + US Certification

About

Emilie Bogart is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques in both urologic and gynecologic oncology. Her work centers on two key areas: the application of robotic stereotactic body radiation therapy (SBRT) for recurrent prostate cancer, and rigorous comparative effectiveness research between robot-assisted and conventional laparoscopy. Her landmark 2017 study on salvage robotic SBRT for local prostate cancer recurrence after radiotherapy (58 citations) demonstrated the feasibility of this non-invasive approach for a patient population with limited standard options. More significantly, Bogart is the principal investigator of the landmark ROBOGYN-1004 randomized trial, which has generated a series of high-impact publications. The primary results (34 citations) provided critical evidence on severe perioperative morbidity, while subsequent analyses examined surgeon ergonomics (18 citations) and the influence of surgical complexity and center experience on outcomes. Her work has directly informed surgical decision-making and training standards in gynecologic oncology, establishing evidence-based benchmarks for the adoption of robotic surgery.